Latest filing published 24 Feb 2026 for ImmunityBio, Inc..
No signal scores available.
This profile gathers the share dealings of Regan J. Lauer in ImmunityBio, Inc. In total, 13 filings cover trades dated from 15 June 2023 to 22 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 24 February 2026, reports a share grant of €12k in ImmunityBio, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations